Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
Table of Contents:; The Human Genome: Foundation for Genomic and Precision Medicine -- The Functional Genome: Epigenetics and Epigenomics -- The State of Whole-Genome Sequencing -- The Human Microbiome -- Quantitative Proteomics for Clinical Translation -- From Data to Knowledge: An Introduction to…
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency SUR Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available |
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency KEL Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available |
c.1 v.1 BC Cancer Agency KEL Library | Available | ||
c.1 v.2 BC Cancer Agency KEL Library | Available | ||
c.1 v.1 BC Cancer Agency VAN Library | Available | ||
c.1 v.2 BC Cancer Agency VAN Library | Available | ||
c.1 v.1 BC Cancer Agency VIC Library REF | Available | ||
c.1 v.2 BC Cancer Agency VIC Library REF | Available |
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
EBMcalc is a unique computerized medical reference and tool set. EBMcalc encompasses a wide array of pertinent medical formulae, clinical criteria sets and decision tree analysis tools used every day by clinicians, medical educators, nurses and health care students.
Table of Contents:; Epidemiology and risk factors for breast cancer -- Primary and secondary prevention of breast cancer --Premalignant changes and in situ carcinoma -- Natural history of invasive breast cancer -- Histology of breast cancer -- Clinical and pathological staging -- Molecular factors …
"Alternative medicine (AM) is popular; about 40% of the US general population have used alternative treatment in the past year, and in Germany this figure is around 70%. The global market is expected to reach nearly US $ 200 billion by 2025, with most of these funds coming directly out of consumers…
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
Summary: